About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
Older
16 Dec 2022
NOX Pipeline Boosted by $1.5M Grant to Hudson Institute
15 Dec 2022
Change of Director's Interest Notice - FB
15 Dec 2022
Notification of cessation of securities - NOX
6 Dec 2022
Federal Innovation Connections Grant Awarded
2 Dec 2022
IONIC Trial Progresses as Veyonda Passes Safety Milestone
21 Nov 2022
Notification of cessation of securities - NOX
17 Nov 2022
Constitution
17 Nov 2022
Results of Meeting
17 Nov 2022
Noxopharm 2022 AGM Corporate Presentation
17 Nov 2022
Noxopharm AGM 2022 Chair's Address
1
2
3
4
5
Next
